Fortrea Holdings Inc. (FTRE) NASDAQ

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Anshul Thakral	Chief Executive Officer & Director	1.69M	1978
Mark A. Morais	Chief Operating Officer & President of Clinical Services	812,667	1977
Jill McConnell	Chief Financial Officer	817,879	1975
Hima Inguva	Head of Corporate Development	0	N/A
Leonard Scott Dove	President of Clinical Pharmacology Services	0	1974
Oren J. Cohen	Chief Medical Officer	0	1961
Alejandro Martinez Galindo	Chief Information Officer	0	N/A
Dave Cooper	Chief Administrative Officer	0	N/A
Drayton Virkler	President & Chief Commercial Officer	0	N/A
Robert Parks	Chief Accounting Officer	0	N/A
Agnieszka Gallagher	General Counsel & Corporate Secretary	0	1974
Sandy Kennedy	Chief Quality, Regulatory Affairs & Sustainability Officer	0	N/A
Tracy H. Krumme	Senior Vice President of Investor Relations	0	1968

Name

Title

Pay

Year Born

Anshul Thakral

Chief Executive Officer & Director

1.69M

1978

Mark A. Morais

Chief Operating Officer & President of Clinical Services

812,667

1977

Jill McConnell

Chief Financial Officer

817,879

1975

Hima Inguva

Head of Corporate Development

N/A

Leonard Scott Dove

President of Clinical Pharmacology Services

1974

Oren J. Cohen

Chief Medical Officer

1961

Alejandro Martinez Galindo

Chief Information Officer

N/A

Dave Cooper

Chief Administrative Officer

N/A

Drayton Virkler

President & Chief Commercial Officer

N/A

Robert Parks

Chief Accounting Officer

N/A

Agnieszka Gallagher

General Counsel & Corporate Secretary

1974

Sandy Kennedy

Chief Quality, Regulatory Affairs & Sustainability Officer

N/A

Tracy H. Krumme

Senior Vice President of Investor Relations

1968

Description

Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.